logo
Fake Ozempic: Court junks pre-arrest bail plea, calls for swift action in pharma scams

Fake Ozempic: Court junks pre-arrest bail plea, calls for swift action in pharma scams

Hindustan Times2 days ago
New Delhi, A Delhi court has dismissed the anticipatory bail plea of a man accused in a multi-million dollar international scam involving the supply of counterfeit pharmaceutical drugs, specifically anti-diabetic drug Ozempic, to foreign entities. Fake Ozempic: Court junks pre-arrest bail plea, calls for swift action in pharma scams
Additional sessions judge Saurabh Partap Singh Laler, who was hearing the pre-arrest bail plea of accused Vicky Ramancha, observed swift legal action against pharmaceutical crimes was essential to maintain India's position as the "pharmacy of the world".
"The supply of counterfeit pharmaceuticals represents a direct threat to public health and safety. Swift legal action against pharmaceutical crimes is essential for maintaining India's position as the pharmacy of the world and protecting legitimate manufacturers from regulatory backlash," the court's August 11 order said.
The accused was stated to be a part of "a sophisticated transnational fraud operation" that purportedly caused financial losses exceeding USD 18.8 million to the complainant company, J Assure Global LLC.
The court noted alleged supply of counterfeit pharmaceutical drugs endangering public health, complex money laundering operations across multiple jurisdictions, and a systematic criminal conspiracy.
On the point of jurisdiction, the court noted Ramancha allegedly used Indian legal systems to lend legitimacy to fraudulent operations and evidence suggested "strategic planning and coordination" from the national capital.
"Modern criminal law recognises that transnational crimes cannot escape prosecution merely because they span multiple jurisdictions."
Calling India's pharmaceutical sector among the "most valuable economic and strategic assets", contributing significantly to national GDP, the court underlined several factors against the grant of the relief.
The accused was stated to be substantial flight risk, given the international operations and financial resources involved, besides the potential for evidence tampering and witness intimidation.
"The discretionary remedy of anticipatory bail cannot be granted in circumstances where allegations involve grave offences against public health and safety, international ramifications threaten India's pharmaceutical industry reputation, a complex investigation requires custodial interrogation and international cooperation, and the grant of bail would undermine public confidence in the criminal justice system," the order said.
Dismissing the plea, the judge said that the case was a reminder that the country's emergence as a global pharmaceutical leader carried with it responsibilities to maintain the highest standards of quality, integrity, and legal compliance.
The court, however, clarified dismissal of the plea did not mean that the accused had to be arrested.
"The investigating agency shall exercise the power of arrest only as a last resort, strictly for the purpose of investigation," it added.
This article was generated from an automated news agency feed without modifications to text.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Publicis sues CCI for denying case files in ad firms' cartelisation probe
Publicis sues CCI for denying case files in ad firms' cartelisation probe

Business Standard

time24 minutes ago

  • Business Standard

Publicis sues CCI for denying case files in ad firms' cartelisation probe

Publicis has sued India's antitrust watchdog for denying access to case files in a high-profile price-fixing investigation of ad agencies, after the French group failed to get the probe stalled until it could review the documents, court filings show. The Competition Commission of India (CCI) shook India's near-$30 billion media and entertainment sector in March with dawn raids at WPP's GroupM, Dentsu, Publicis, Omnicom and many other agencies over suspected collusion over publicity rates and discounts. Details of cartel cases are kept confidential in India, but Reuters has reported that the CCI's initial assessment found the firms used a WhatsApp group to coordinate and agree on pricing, entered into secret pacts, and colluded with broadcasters to deny business to agencies that didn't comply. Concerned the CCI has not responded to its requests in recent months to provide access to case files, Publicis approached the Delhi High Court on August 11 asking judges to order the watchdog to accede to its requests, according to its non-public filing reviewed by Reuters on Thursday. Publicis and its employees in India are "unable to understand the allegations against them and prepare a defence in the absence of the case records", it said in the filing. The CCI did not respond to Reuters queries, and the court is likely to hear Publicis' case next week. The filing was made by TLG India, which its court papers said "is the legal entity that houses majority of the advertising business of the Publicis group in India". The antitrust investigation was triggered by Dentsu disclosing alleged industry malpractices to the CCI in February 2024 under the regulator's leniency program, which allows lesser penalties for firms that share evidence of malpractice. Publicis is the first company to file a lawsuit related to the high-profile CCI investigation in court. Filings showed the company urged the CCI in July that "further investigation remain in abeyance till" it is granted inspection of case records. CCI investigations typically take several months. The regulator has powers to impose financial penalties on the media agencies of up to three times their profit or 10 per cent of an Indian entity's global turnover, whichever is higher, for each year of wrongdoing. Publicis' court filing also showed the CCI in July asked for a brief note from the company about its business model, and how operations are coordinated with the parent entity. On August 4, the CCI issued summons to Publicis' South Asia chief Anupriya Acharya to appear before investigators, and provide documents such as copies of key contracts involving Publicis and its Indian entities, including on revenue sharing. Acharya did not respond to Reuters queries, and Publicis has asked the court to quash the summon.

Tehran movie review: This John Abraham-starrer is a compelling spy drama
Tehran movie review: This John Abraham-starrer is a compelling spy drama

Indian Express

timean hour ago

  • Indian Express

Tehran movie review: This John Abraham-starrer is a compelling spy drama

Tehran review: It's raining spies everywhere you turn, but it's in 'Tehran' that you actually get a sense of what the work entails– it could mean putting in long, hard hours in nondescript offices, and the field operations that are shown as fast-paced car-and-copter-chases in the movies is, in this John Abraham-starrer, mostly about learning how to hide in plain sight, even as the danger of betrayal looms at every step. Abraham plays Rajeev Kumar, an intelligence officer who gets embroiled in the dirty business involving two foreign nations, Israel and Iran, on Indian soil. A blast in New Delhi results in the death of a little girl, a bystander with zero stakes in the long-standing conflict in the Middle East, and RK finds himself moving from the periphery to the centre. It's no longer about the job; it is now personal. The unravelling of the conspiracy, with the help of his team-mates Shailaja, Divya, Vijay (Neeru Bajwa, Manushi Chillar, Dinker Sharma) takes him from jousting with officials (Aly Khan, Quashik Mukherjee) in the Capital's power corridors, to the streets of Tehran. Some suspects are rounded up and tortured– some of these scenes are brutal but matter-of-fact, business-as-usual to get crucial information out. The plot, in trying to uncover the connections between the conspirators in Iran and Israel, does get confused and choppy in places. There is, for example, a horrifying sequence where an old man (whom we later learn is a rabbi) is mutilated and hammered to death with the murderer wearing a thin plastic overcoat to save his clothes from the blood. There's a slogan about Palestine scrawled on the wall behind him, with many other lines beneath. The film is set in 2012, when the car bomb goes off, and in the credits we see the line, 'inspired by true events'. But the fact that it's out now, with the Gaza conflict at its peak, is one of those coincidences that even the movies cannot dream up. It tells us that the Middle East has been on the boil for a long time: at this moment, an end doesn't seem to be in sight, but after this incident, the warring nations have taken their dirty business off Indian soil. That's what 'Tehran' leaves us with. What Abraham, whose impassivity helps his character feel as real as it can when done with reel-drama (Chillar's jagged hair-cut is very stylish, and not just for a spy), manages to pull off here is noteworthy. Interesting faces make up the ensemble. Characters In Tehran speak in Farsi, with subtitles below; he himself uses the language briefly with a degree of fluidity. And while it takes some time to warm up, the film finds its moral centre in the violent death of a spy: yes, it happened, and yes, it was while they were on duty, but it can leave a teammate stunned, and another can just hand out a pat on the shoulder, while fully understanding and sharing that pain, because the operation is still underway. Also Read | War 2 movie review: Hrithik Roshan, Jr NTR, Kiara Advani spy saga is so limp, you're left looking for zing This sequence made the movie for me. As did a tear running unobtrusively down RK's eye. Spies die for their country and each death leaves an absence. Tehran movie cast: John Abraham, Neeru Bajwa, Manushi Chillar, Madhurima Tuli, Aly Khan, Quashik Mukherjee, Dinker Sharma, Hadi Khanjanpour Tehran movie director: Arun Gopalan Tehran movie rating: Two and a half stars

Who is Deon Lewis? Green card holder detained by ICE begs for deportation
Who is Deon Lewis? Green card holder detained by ICE begs for deportation

Hindustan Times

timean hour ago

  • Hindustan Times

Who is Deon Lewis? Green card holder detained by ICE begs for deportation

A green card holder has asked to be deported from the US, saying he is in chronic pain in a Texas immigration detention center, where he claims he has not received treatment for sickle cell disease, the Houston Chronicle reported. Held in ICE custody, Deon Lewis waived appeal rights to speed up deportation, saying his health is failing and detention conditions are worsening his condition.(GofundMe) Who is Deon Lewis? Deon Lewis, 43, has been a legal permanent resident since 1993. He was born with a condition that affects blood flow, can cause severe pain, and may lead to organ damage or stroke. 'It's only a matter of time before something really bad happens to me,' he told the Houston Chronicle. 'Why haven't I been deported yet? I've been begging these people to deport me.' A member of his legal team has even pointed to his criminal record to push for faster deportation so he can get treatment. President Donald Trump has ordered his administration to remove millions of undocumented migrants as part of his pledge for mass deportations. Also Read: Indian man claims deportation from UK after 30 years, friends see him off at airport: 'They are deporting him' Along with people without legal status, some immigrants with valid documents, including green cards and visas, have also been detained. Immigration authorities have faced more scrutiny amid misconduct claims, with ICE at the center of the immigration debate. Lewis has had lung surgery and previously had medication that helped him function, the outlet reported. He has been held in Houston since June 30 after being detained earlier in Louisiana, according to the Chronicle. His lawyers say he has been denied medication in Texas and has fainted from pain. In mid-July, he agreed to a stipulated removal order, waiving his right to appeal or seek judicial review, saying his main goal is to be released. Deon Lewis was arrested in 2002 and 2020 Lewis has a criminal record going back to 2002, when he was arrested for cocaine possession, pleaded guilty, and was put on probation. In 2020, he was arrested again on marijuana and cocaine possession charges and for carrying a firearm. 'I've been in this country since I was 11 years old. Yeah, I did something wrong,' he said. 'Since then, I went on to start my own business. I've got five children that I take care of. I've never been on child support for any of them,' he told the outlet. An ICE spokesperson said, 'He is the definition of a threat to public safety and will remain in ICE custody until his removal can be carried out.' Lewis said he and his wife, Roxanne Lewis, have offered to pay his travel costs themselves to speed up his release. 'And that's without me even knowing what I'm going into. I just want to get out of here so I can get medical attention,' Lewis said. Deon Lewis is a business owner Roxanne wrote on GoFundMe, 'Deon is an asset to his community and has been for over 30 years in the United States. He is a business owner. Providing jobs and transportation to the public. Please help Deon to be released and free from this horrible situation which has affected, devastated, destroying all of us so much.' Rina Gandhi, one of Lewis' attorneys, told the Houston Chronicle, 'He's not fighting or disputing removal — he's trying to leave due to his severe health concerns and everyone agrees to his removal. So why is he still here? His rap sheet shouldn't matter. If anything, it should speed things up.' Lewis will remain in ICE custody until removal proceedings are completed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store